{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "23809241",
  "DateCompleted": {
    "Year": "2013",
    "Month": "09",
    "Day": "13"
  },
  "DateRevised": {
    "Year": "2019",
    "Month": "03",
    "Day": "18"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/j.bpg.2012.12.007",
      "S1521-6918(13)00073-5"
    ],
    "Journal": {
      "ISSN": "1532-1916",
      "JournalIssue": {
        "Volume": "27",
        "Issue": "2",
        "PubDate": {
          "Year": "2013",
          "Month": "Apr"
        }
      },
      "Title": "Best practice & research. Clinical gastroenterology",
      "ISOAbbreviation": "Best Pract Res Clin Gastroenterol"
    },
    "ArticleTitle": "Precancerous lesions in the stomach: from biology to clinical patient management.",
    "Pagination": {
      "StartPage": "205",
      "EndPage": "223",
      "MedlinePgn": "205-23"
    },
    "Abstract": {
      "AbstractText": [
        "Gastric cancer is the final step in a multi-stage cascade triggered by long-standing inflammatory conditions (particularly Helicobacter pylori infection) resulting in atrophic gastritis and intestinal metaplasia: these lesions represent the cancerization field in which (intestinal-type) gastric cancer develops. Intraepithelial neoplasia is consistently recognized as the phenotypic bridge between atrophic/metaplastic lesions and invasive cancer. This paper addresses the epidemiology, pathology, molecular profiling, and clinical management of advanced precancerous gastric lesions."
      ],
      "CopyrightInformation": "Copyright \u00a9 2013. Published by Elsevier Ltd."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Medicine - DIMED, Surgical Pathology & Cytopathology Unit, University of Padova, Padova, Italy. massimo.rugge@unipd.it"
          }
        ],
        "LastName": "Rugge",
        "ForeName": "Massimo",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Capelle",
        "ForeName": "Lisette G",
        "Initials": "LG"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Cappellesso",
        "ForeName": "Rocco",
        "Initials": "R"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Nitti",
        "ForeName": "Donato",
        "Initials": "D"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Kuipers",
        "ForeName": "Ernst J",
        "Initials": "EJ"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Netherlands",
    "MedlineTA": "Best Pract Res Clin Gastroenterol",
    "NlmUniqueID": "101120605",
    "ISSNLinking": "1521-6918"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [
        "epidemiology",
        "pathology",
        "therapy"
      ],
      "DescriptorName": "Gastritis, Atrophic"
    },
    {
      "QualifierName": [
        "epidemiology",
        "pathology",
        "therapy"
      ],
      "DescriptorName": "Helicobacter Infections"
    },
    {
      "QualifierName": [
        "pathogenicity"
      ],
      "DescriptorName": "Helicobacter pylori"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "epidemiology",
        "pathology",
        "therapy"
      ],
      "DescriptorName": "Precancerous Conditions"
    },
    {
      "QualifierName": [
        "epidemiology",
        "pathology",
        "therapy"
      ],
      "DescriptorName": "Stomach Neoplasms"
    }
  ]
}